ADC Therapeutics SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADCT New York 2836 www.adctherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADC Therapeutics SA

ADC Therapeutics Makes Grant to New Employee Under Inducement Plan - Jul 1st, 2025 2:05 pm
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML) - Jun 16th, 2025 5:15 am
ADC Therapeutics to Cut 30% of Workforce, Shutter UK Site - Jun 12th, 2025 6:31 am
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028 - Jun 12th, 2025 4:45 am
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress - Jun 12th, 2025 4:30 am
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - Jun 2nd, 2025 2:05 pm
AbbVie’s ADC win shows how pharma can break through in solid tumors - May 30th, 2025 3:44 am
Analysts Are Upgrading ADC Therapeutics SA (NYSE:ADCT) After Its Latest Results - May 17th, 2025 6:56 am
ADC Therapeutics ends development of ADCT-602 and unveils latest Zynlonta data - May 15th, 2025 5:49 am
ADC Therapeutics to Present at Upcoming Investor Conferences - May 15th, 2025 5:15 am
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates - May 14th, 2025 7:10 am
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - May 14th, 2025 6:00 am
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML) - May 14th, 2025 5:45 am
Zymeworks Inc. (ZYME) Reports Q1 Loss, Tops Revenue Estimates - May 8th, 2025 3:50 pm
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025 - May 8th, 2025 5:15 am
Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates - May 1st, 2025 3:25 pm
AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates - Apr 30th, 2025 6:15 am
Agenus (AGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Apr 29th, 2025 8:01 am
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Apr 28th, 2025 8:00 am
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025 - Apr 28th, 2025 5:00 am